Apptomics: Entering the World of Digital Therapeutics

Apptomics: Entering the World of Digital Therapeutics

Posted by BBK Worldwide on Thu, Nov 8, 2018

Georgia Mitsi spoke with BBK Worldwide®’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”

“You can find a thousand of these apps in the Apple Store; the mission we have in the company is about creating tools that have the scientific validation needed.”

“I wanted to create something that has the scientific validation, can be used in clinical trials and also in every day life, in patients’ lives, but also should be considered as part of the standard-of-care.”

Mitsi discusses her aspirations for her company’s newest App E.V.A, why it’s named for her daughter, why she initially landed on the side of a provision device, and why she’s a little bit conservative when it comes to the world of digital devices.

Do you agree with Mitsi’s conclusion that it’s better to be a bit conservative in the new world of digital?


Topics: Disruptive Innovation, Clinical Research, Clinical Trials, Pharma15 Live!, Most Viewed, Digital, Provisional Device, Devices, BYOD